Selective intestinal decontamination in advanced chronic heart failure: A pilot trial

European Journal of Heart Failure

Volumn 6, Issue 4, 2004, Pages 483-491

  Conraads, Viviane M ^a   Jorens, Philippe G ^a   De Clerck, Luc S ^a   Van Saene, Hendrik K ^b   Ieven, Margaretha M ^a   Bosmans, Johan M ^a   Schuerwegh, Annemie ^a   Bridts, Chris H ^a   Wuyts, Floris ^a   Stevens, Wim J ^a   Anker, Stefan D ^c   Rauchhaus, Mathias ^d   Vrints, Christiaan J ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Chronic heart failure; Endothelial dysfunction; Endotoxin; Inflammation; Selective digestive decontamination

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POLYMYXIN B; TOBRAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEFECATION; DIGESTIVE SYSTEM; DISEASE COURSE; FEMALE; GRAM NEGATIVE BACTERIUM; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; INTESTINE; INTESTINE MOTILITY; MALE; MONOCYTE; PATIENT SELECTION; PILOT STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STIMULATION; TREATMENT WITHDRAWAL;

ADULT; AGED; ANTIGENS, CD14; BACTERIOLOGICAL TECHNIQUES; BIOLOGICAL MARKERS; CHRONIC DISEASE; CYTOKINES; DECONTAMINATION; ENDOTHELIUM, VASCULAR; ENDOTOXINS; FECES; FEMALE; GRAM-NEGATIVE AEROBIC BACTERIA; HEART FAILURE, CONGESTIVE; HUMANS; INTESTINES; MALE; MIDDLE AGED; MONOCYTES; PILOT PROJECTS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; SEVERITY OF ILLNESS INDEX; VASODILATION;

EID: 2942625803     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.12.004     Document Type: Article

References (32)

1. Ferrari R., Bachetti T., Confortini R., et al. Tumor necrosis factor soluble receptor in patients with various degrees of congestive heart failure. Circulation. 92:1995;1479-1486
2. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 27:1996;1201-1206
3. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 102:2000;3060-3067
4. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., Mann D.L. Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from vesnarinone trial (VEST). Circulation. 103:2001;2055-2059
5. Niebauer J., Volk H., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 353:1999;1838-1842
6. Lequier L.L., Nikaidoh H., Leonard S.R., et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest. 117:2000;1706-1712
7. Koloczek V., Rauchhaus M., Kemp M., Bjarnason I., Coats A.J.S., Anker S.D. Markers of intestinal ischaemia relate to proinflammatory cytokines in patients with congestive heart failure. Eur Heart J. 21:2000;662. Abstr
8. Van Saene J.J.M., Stoutenbeek C.P., van Saene H.K.F., Matera G., Martinez-Pellus A.E., Ramsay G. Reduction of the intestinal endotoxin pool by three different SDD regimens in human volunteers. J Endotox Res. 3:1996;337-343
9. Leigh D.A., Walsh B., Leung A., Tait S., Peatey K., Hancock P. The effect of cefuroxime axetil on the faecal flora of healthy volunteers. J Antimicrob Chemother. 26:1990;261-268
10. Rauchhaus M., Doehner W., Bolger A., et al. Endotoxin and severity of chronic heart failure. J Am Coll Cardiol. 39:(Suppl):2001;190A. Abstr
11. Schuerwegh A.J., Stevens W.J., Bridts C.H., De Clerck L.S. Evaluation of monensin and brefeldin A for flow cytometric determination of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in monocytes. Cytometry. 46:2001;172-176
12. Hijmering M.L., Stroes E.S., Olijhoek J., Hutten B.A., Blankestijn P.J., Rabelink T.J. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol. 39:2002;683-688
13. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115
14. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 39:2002;257-265
15. Anker S.D., Egerer K.R., Volk H., Kox W.J., Poole-Wilson P.A., Coats A.J.S. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 79:1997;1426-1430
16. Landmann R., Knopf H.P., Link S., Sansano S., Schumann R., Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun. 64:1996;1762-1769
17. Pajkrt D., Lerch P.G., van der Poll T., et al. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thromb Haemostasis. 77:1997;303-307
18. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711
19. Yue P., Massie B.M., Simpson P.C., Long C.S. Cytokine expression increases in non-myocytes from rats with postinfarction heart failure. Am J Physiol. 275:(1 Pt2):1998;H250-H258
20. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 31:1998;391-398
21. Vanderheyden M., Kersschot E., Paulus W.J. Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure. Eur Heart J. 19:1998;747-752
22. Dutka D.P., Elborn J.S., Delamere F., Shale D.J., Morris G.K. Tumour necrosis factor alpha in severe congestive cardiac failure. Br Heart J. 70:1993;141-143
23. Dibbs Z., Thornby J., White B.G., Mann D.L. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol. 33:1999;1935-1942
24. Schwarz N.T., Beer-Stolz D., Simmons R.L., Bauer A.J. Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis. Ann Surg. 235:2002;31-40
25. Rauchhaus M., Coats A.J., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet. 356:2000;930-933
26. Drexler H., Hayoz D., Münzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 69:1992;1596-1601
27. Agnoletti L., Curello S., Bachetti T., et al. Serum from patients with severe heart failure down regulates eNOS and is proapoptotic: role of tumor necrosis factor alpha. Circulation. 100:1999;1983-1991
28. Ferrari R., Bachetti T., Agnoletti L., Comini L., Curello S. Endothelial function and dysfunction in heart failure. Eur Heart J. 19:1998;G41-G47
29. Fichtlscherer S., Rössig L., Breuer S., Vasa M., Dimmeler S., Zeiher A.M. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation. 104:2001;3023-3025
30. Aukrust P., Ueland T., Müller F., et al. Elevated circulating levels of C-chemokines in patients with congestive heart failure. Circulation. 97:1998;1136-1143
31. Verma S., Hyndman E., Robertson A., et al. Neopterin: novel marker of endothelial dysfunction in humans. Circulation. 104:(Suppl II):2002;152. Abstr
32. Dybdahl B., Wahba A., Lien E., et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation. 106:2002;685-690